Kwangdong Phar - Asset Resilience Ratio
Kwangdong Phar (009290) has an Asset Resilience Ratio of 6.53% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Kwangdong Phar (009290) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2025)
This chart shows how Kwangdong Phar's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Kwangdong Phar's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Kwangdong Phar's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 009290 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩86.09 Billion | 6.53% |
| Total Liquid Assets | ₩86.09 Billion | 6.53% |
Asset Resilience Insights
- Limited Liquidity: Kwangdong Phar maintains only 6.53% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Kwangdong Phar Industry Peers by Asset Resilience Ratio
Compare Kwangdong Phar's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Nestle India Limited
NSE:NESTLEIND |
Packaged Foods | 1.07% |
|
Grupo Bimbo S.A.B. de C.V
MX:BIMBOA |
Packaged Foods | 0.15% |
|
Guangdong Haid Group Co Ltd
SHE:002311 |
Packaged Foods | 5.88% |
|
Maple Leaf Foods Inc.
TO:MFI |
Packaged Foods | 4.21% |
|
JiangXi Tianxin Pharm Co Ltd
SHG:603235 |
Packaged Foods | 4.40% |
|
Bright Dairy & Food Co Ltd
SHG:600597 |
Packaged Foods | 0.02% |
|
Beijing Sanyuan Foods Co Ltd
SHG:600429 |
Packaged Foods | 0.10% |
|
Yan Tai Shuang Ta Food Co Ltd
SHE:002481 |
Packaged Foods | 0.01% |
Annual Asset Resilience Ratio for Kwangdong Phar (2011–2025)
The table below shows the annual Asset Resilience Ratio data for Kwangdong Phar.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.57% | ₩86.70 Billion ≈ $58.75 Million |
₩1.32 Trillion ≈ $894.77 Million |
+2.36pp |
| 2024-12-31 | 4.21% | ₩49.26 Billion ≈ $33.38 Million |
₩1.17 Trillion ≈ $793.08 Million |
-7.74pp |
| 2023-12-31 | 11.95% | ₩128.84 Billion ≈ $87.31 Million |
₩1.08 Trillion ≈ $730.59 Million |
+0.68pp |
| 2022-12-31 | 11.27% | ₩105.08 Billion ≈ $71.21 Million |
₩932.02 Billion ≈ $631.62 Million |
-0.46pp |
| 2021-12-31 | 11.74% | ₩103.74 Billion ≈ $70.30 Million |
₩883.85 Billion ≈ $598.97 Million |
+0.37pp |
| 2020-12-31 | 11.36% | ₩94.39 Billion ≈ $63.97 Million |
₩830.64 Billion ≈ $562.92 Million |
+6.63pp |
| 2019-12-31 | 4.73% | ₩37.50 Billion ≈ $25.41 Million |
₩792.78 Billion ≈ $537.25 Million |
-2.55pp |
| 2018-12-31 | 7.28% | ₩53.28 Billion ≈ $36.11 Million |
₩732.06 Billion ≈ $496.10 Million |
+0.06pp |
| 2017-12-31 | 7.22% | ₩52.18 Billion ≈ $35.36 Million |
₩722.70 Billion ≈ $489.76 Million |
-0.53pp |
| 2016-12-31 | 7.75% | ₩52.69 Billion ≈ $35.71 Million |
₩679.78 Billion ≈ $460.68 Million |
+0.47pp |
| 2015-12-31 | 7.28% | ₩48.30 Billion ≈ $32.73 Million |
₩663.79 Billion ≈ $449.84 Million |
-3.44pp |
| 2014-12-31 | 10.72% | ₩47.43 Billion ≈ $32.14 Million |
₩442.53 Billion ≈ $299.90 Million |
+1.17pp |
| 2013-12-31 | 9.55% | ₩40.66 Billion ≈ $27.56 Million |
₩425.68 Billion ≈ $288.47 Million |
+2.24pp |
| 2012-12-31 | 7.31% | ₩28.46 Billion ≈ $19.29 Million |
₩389.43 Billion ≈ $263.91 Million |
-2.78pp |
| 2011-12-31 | 10.09% | ₩32.47 Billion ≈ $22.00 Million |
₩321.68 Billion ≈ $218.00 Million |
-- |
About Kwangdong Phar
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti… Read more